AtlasXomics

BiotechnologySeries ANew Haven, USatlasxomics.com

Latest round

Series A

Last raised

Dec 2021

Total raised

$3.9M

Investors

1

About AtlasXomics

Based in Connecticut, US, and founded in 2020 by Rong Fan, AtlasXomics Inc. is a Yale spin-out and operates as a comprehensive spatial epigenome solution that gives researchers unprecedented insight into genomics, transcriptomics, and proteomics landscapes. In December 2021, AtlasXomics Inc. AtlasXomics Inc. offers Deterministic Barcoding in Tissue for spatial omics sequencing (DBiT-seq) platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases that leverages microfluidics and next-generation sequencing (NGS) to create transformative multi-omic maps (proteomics, transcriptomics, and epigenomics) of tissue at cellular resolution. The company provides a detailed data report that consists of sample optimization, clustering, browser tracks, a detailed summary, gene accessibility maps, and motif analysis for the investigator to use in research.

Who invested in AtlasXomics

1 investor across 1 round

See all investors in AtlasXomics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 22, 2021

    Amount

    $3.9M

    Investors

    Locked

Questions about AtlasXomics

Who invested in AtlasXomics?

AtlasXomics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has AtlasXomics raised?

AtlasXomics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did AtlasXomics last raise money?

AtlasXomics's most recent round on record is a Series A, in Dec 2021.

What does AtlasXomics do?

Based in Connecticut, US, and founded in 2020 by Rong Fan, AtlasXomics Inc.

Where is AtlasXomics headquartered?

AtlasXomics is headquartered in New Haven, US.

Which VCs invest in companies like AtlasXomics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AtlasXomics's stage. Their profiles are linked below.

Raising like AtlasXomics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.